Table 3.

Results of collaborative study for the 1 TD of lethal titer and hemorrhagic titer determination

Test	1 TD of Lethal titer (μg)¶					1 TD of Hemorrhagic titer (μg)¶
	1*	2†	3‡	4§	5||	1*	2†	3‡	4§
1	94.20	103.77	94.20	107.92	85.86	8.50	12.18	11.28	11.08
2	78.58	94.20	94.20	107.92	102.65	8.87	10.99	11.44	8.99
3	86.37	86.37	96.00	107.92	96.00	10.13	10.48	11.33	9.14
4	68.37	94.20	96.00	86.37	89.78	8.67	10.81	11.26	9.69
5	78.58	78.58	94.20	86.37	89.78	9.41	10.70	10.78	10.11
6	94.20	94.35	86.37			10.87	12.23	11.40
7	86.37	94.20	86.37			11.36	11.19	11.84
8	94.20	96.00	86.37			11.19	10.89	11.81
9	98.23	86.37	94.20			10.22	10.65	9.73
10	96.00	78.58	94.20			10.94	11.38	11.38
Common potency (%)	87.51	90.66	92.21	99.30	92.81	10.02	11.15	11.23	9.80
95% confidence interval	81.49	85.69	89.67	88.95	87.04	9.34	10.77	10.85	9.06
	~93.53	~95.64	~94.75	~109.65	~98.59	~10.69	~11.53	~11.60	~10.54
Coefficients of variation	11.10	8.86	4.44	11.89	7.10	10.84	5.51	5.37	8.59
General common potency	90.13			-	-	10.80			-

^*National Institute of Food and Drug Safety Evaluation (NIFDS), Cheongju, Korea.

^†Osong Medical Innovation Foundation (KBIO), Cheongju, Korea.

^‡Koreavaccine co., Ansan, Korea.

^§National Institute of Infectious Diseases (NIID), Tokyo, Japan.

^||National Quality Control Laboratory of Drug and Food (NQCLDF), Central Jakarta, Indonesia.

^¶Titers are expressed as μg per animal. Standardization of NRS for Snake Venom in Korea 195